Infusion therapies in rheumatic practice

Citation
O. Gluck et M. Maricic, Infusion therapies in rheumatic practice, JCR-J CLIN, 6(5), 2000, pp. 294-299
Citations number
37
Categorie Soggetti
Rheumatology
Journal title
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
ISSN journal
10761608 → ACNP
Volume
6
Issue
5
Year of publication
2000
Pages
294 - 299
Database
ISI
SICI code
1076-1608(200010)6:5<294:ITIRP>2.0.ZU;2-A
Abstract
Infusion therapies have been used in rheumatology practice for many years. However, the recent approval of infliximab for rheumatoid arthritis and the development of a host of i.v. treatments for inflammatory rheumatic and me tabolic bone disorders will Likely have a significant impact on the use of infusion therapies by rheumatologists. Current i.v therapies for rheumatic disorders include pulse corticosteroids , infliximab, cyclophosphamide, i.v. gammaglobulin, and pamidronate. This r eview discusses specific indications, adverse events and general requiremen ts for administration of each of these therapies. Appropriate screening gen erally includes a CBC and evaluation of past allergies, renal and Liver fun ction, and cardiac status. Supplies for treatment of possible anaphylaxis s hould be available.